Author Information
Author: Professor Adebambo Adewopo
Affiliation: Nigerian Institute of Advanced Legal Studies, Abuja, Nigeria
Paper Details
Title: Access to Pharmaceutical Patents in the COVID-19 Emergency: A Case for Government Use in Nigeria
Author: Adebambo Adewopo
Journal: Journal of African Law
Volume: 65
Issue: S2
Year: 2021
Pages: 259–286
Publisher: Cambridge University Press
DOI: 10.1017/S0021855321000334
Overview
This article examines access to pharmaceutical patents during the COVID-19 pandemic and discusses how government use provisions under Nigerian patent law can help improve access to vaccines and essential medicines. The paper focuses on the role of intellectual property law, compulsory licensing, and government intervention in addressing public health emergencies, particularly in Nigeria and Sub-Saharan Africa.
Main Areas Discussed
- Pharmaceutical patents and public health
- COVID-19 vaccine access
- Compulsory licensing under Nigerian law
- Government use provisions
- TRIPS Agreement and flexibilities
- Patent law and public health emergencies
- Access to medicines in Sub-Saharan Africa
Key Themes
- Intellectual property and public health
- COVID-19 vaccine access
- Government use of patents
- Compulsory licensing
- Access to essential medicines
- Patent law and emergency response
Suggested Citation
Adewopo, Adebambo
Access to Pharmaceutical Patents in the COVID-19 Emergency: A Case for Government Use in Nigeria
Journal of African Law, Vol. 65, Issue S2 (2021), pp. 259–286
